연구성과로 돌아가기
JCR 2022 저널 목록 (480 / 2070)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TEXAS LAW REVIEW | TEXAS LAW REVIEW PUBL INC | 0040-4411 | 1942-857X | SSCI | LAW | 1,610 | 1.6 | Q2 | 34.7 | 65.3 | 54/154 | 2.0 | Q2 | 1.5 | 0.4 | 1.42 | 68/425 | Q1 | 84.12 | 0.002 | 0.396 | 1.240 | Q1 | 36 | 97.2% | 14.2 | 11.1 | 35 | 0.0% | 2025-04-21 10:07:33 | 바로가기 |
| Tobacco Induced Diseases | EUROPEAN PUBLISHING | 1617-9625 | 1617-9625 | SSCI | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 1,597 | 3.7 | Q2 | 34.7 | 65.3 | 63/180 | 3.3 | Q2 | 3.5 | 0.3 | 0.63 | 210/400 | Q3 | 47.63 | 0.003 | 0.616 | 0.870 | Q2 | 97 | 93.8% | 3.6 | 6.1 | 91 | 98.8% | 2025-04-21 10:32:45 | 바로가기 |
| VASCULAR PHARMACOLOGY | ELSEVIER SCIENCE INC | 1537-1891 | 1879-3649 | SCIE | PHARMACOLOGY & PHARMACY | 3,852 | 4.0 | Q2 | 34.7 | 65.3 | 97/278 | 4.8 | Q2 | 3.9 | 2.2 | 1.17 | 57/366 | Q1 | 84.56 | 0.002 | 0.526 | 0.879 | Q2 | 69 | 89.9% | 6.6 | 6.7 | 62 | 17.9% | 2025-04-21 10:24:24 | 바로가기 |
| VIRUS RESEARCH | ELSEVIER | 0168-1702 | 1872-7492 | SCIE | VIROLOGY | 13,719 | 5.0 | Q2 | 34.7 | 65.3 | 13/36 | 4.0 | Q2 | 4.9 | 0.9 | 0.70 | 18/41 | Q2 | 57.32 | 0.010 | 2.175 | 0.873 | Q2 | 281 | 95.0% | 7.8 | 7.7 | 267 | 19.4% | 2025-04-21 10:40:56 | 바로가기 |
| CALCIFIED TISSUE INTERNATIONAL | SPRINGER | 0171-967X | 1432-0827 | SCIE | ENDOCRINOLOGY & METABOLISM | 8,718 | 4.2 | Q2 | 34.8 | 65.2 | 51/145 | 4.1 | Q2 | 4.1 | 0.9 | 0.81 | 73/184 | Q2 | 60.60 | 0.006 | 1.239 | 0.940 | Q2 | 111 | 80.2% | 9.2 | 8.4 | 89 | 29.8% | 2025-04-21 09:50:19 | 바로가기 |
| CRISPR Journal | MARY ANN LIEBERT, INC | 2573-1599 | 2573-1602 | SCIE | GENETICS & HEREDITY | 896 | 3.7 | Q2 | 34.8 | 65.2 | 60/171 | 4.3 | Q2 | 3.6 | 1.3 | 0.93 | 50/189 | Q2 | 73.81 | 0.003 | 0.658 | 1.830 | Q1 | 71 | 81.7% | 2.6 | 5.4 | 58 | 20.6% | 2025-04-21 09:58:15 | 바로가기 |
| Current Diabetes Reports | CURRENT MEDICINE GROUP | 1534-4827 | 1539-0829 | SCIE | ENDOCRINOLOGY & METABOLISM | 7,081 | 4.2 | Q2 | 34.8 | 65.2 | 51/145 | 5.7 | Q1 | 4.2 | 1.4 | 0.60 | 112/184 | Q3 | 39.40 | 0.008 | 1.658 | 1.487 | Q1 | 54 | 0.0% | 6.2 | 6.3 | 0 | 16.8% | 2025-04-21 09:50:20 | 바로가기 |
| Egyptian Informatics Journal | CAIRO UNIV, FAC COMPUTERS & INFORMATION | 1110-8665 | 2090-4754 | SCIE | COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE | 1,245 | 5.2 | Q2 | 34.8 | 65.2 | 51/145 | 5.0 | Q2 | 5.1 | 1.5 | 1.16 | 42/192 | Q1 | 78.39 | 0.001 | 0.156 | 0.616 | Q3 | 60 | 96.7% | 4.8 | 5.5 | 58 | 85.7% | 2025-04-21 09:40:57 | 바로가기 |
| Endocrine Practice | ELSEVIER INC | 1530-891X | 1934-2403 | SCIE | ENDOCRINOLOGY & METABOLISM | 6,144 | 4.2 | Q2 | 34.8 | 65.2 | 51/145 | 3.8 | Q3 | 4.1 | 1.5 | 0.87 | 65/184 | Q2 | 64.95 | 0.007 | 1.490 | 1.095 | Q2 | 139 | 79.9% | 6.2 | 6.6 | 111 | 8.0% | 2025-04-21 09:50:21 | 바로가기 |
| Environmental Hazards-Human and Policy Dimensions | TAYLOR & FRANCIS LTD | 1747-7891 | 1878-0059 | SSCI | ENVIRONMENTAL STUDIES | 1,342 | 4.0 | Q2 | 34.8 | 65.2 | 45/128 | 3.1 | Q3 | 3.8 | 0.3 | 0.69 | 88/179 | Q2 | 51.12 | 0.001 | 0.189 | 0.674 | Q3 | 22 | 100.0% | 10.2 | 7.5 | 22 | 12.4% | 2025-04-21 09:56:03 | 바로가기 |
| Epigenetics | TAYLOR & FRANCIS INC | 1559-2294 | 1559-2308 | SCIE | GENETICS & HEREDITY | 6,523 | 3.7 | Q2 | 34.8 | 65.2 | 60/171 | 4.6 | Q2 | 3.6 | 0.6 | 0.77 | 79/189 | Q2 | 58.47 | 0.006 | 1.246 | 1.182 | Q2 | 98 | 94.9% | 7.5 | 7.2 | 93 | 36.7% | 2025-04-21 09:58:02 | 바로가기 |
| Forest Policy and Economics | ELSEVIER | 1389-9341 | 1872-7050 | SSCI | ENVIRONMENTAL STUDIES | 6,573 | 4.0 | Q2 | 34.8 | 65.2 | 45/128 | 3.9 | Q2 | 3.7 | 1.0 | 1.23 | 43/179 | Q1 | 76.26 | 0.006 | 1.265 | 0.715 | Q3 | 102 | 96.1% | 5.4 | 7.6 | 98 | 28.5% | 2025-04-21 09:55:55 | 바로가기 |
| Frontiers in Genetics | FRONTIERS MEDIA SA | N/A | 1664-8021 | SCIE | GENETICS & HEREDITY | 36,301 | 3.7 | Q2 | 34.8 | 65.2 | 60/171 | 4.3 | Q2 | 3.4 | 0.6 | 0.88 | 57/189 | Q2 | 70.11 | 0.053 | 11.639 | 0.939 | Q2 | 3582 | 89.1% | 3.0 | 6.2 | 3192 | 99.4% | 2025-04-21 09:57:57 | 바로가기 |
| GENES CHROMOSOMES & CANCER | WILEY | 1045-2257 | 1098-2264 | SCIE | GENETICS & HEREDITY | 5,511 | 3.7 | Q2 | 34.8 | 65.2 | 60/171 | 3.9 | Q2 | 3.4 | 0.8 | 0.78 | 75/189 | Q2 | 60.58 | 0.004 | 0.969 | 1.157 | Q2 | 78 | 88.5% | 10.1 | 5.6 | 69 | 21.1% | 2025-04-21 09:58:03 | 바로가기 |
| JOURNAL OF INHERITED METABOLIC DISEASE | WILEY | 0141-8955 | 1573-2665 | SCIE | ENDOCRINOLOGY & METABOLISM | 7,548 | 4.2 | Q2 | 34.8 | 65.2 | 51/145 | 4.6 | Q2 | 3.9 | 0.7 | 1.02 | 43/184 | Q1 | 76.90 | 0.006 | 1.332 | 1.250 | Q2 | 91 | 84.6% | 9.1 | 8.9 | 77 | 38.1% | 2025-04-21 09:50:20 | 바로가기 |
페이지 이동: